The efficacy of acupuncture on chemotherapy-induced peripheral neuropathy receiving standard treatment in patients with breast cancer

Not Applicable

Recruiting

• Conditions: Diseases of the nervous system

• Registration Number: KCT0008943
• Lead Sponsor: Kyung Hee University Oriental Medicine Hospital at Gangdong

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

• aged = 19 years old
• histologically confirmed stage I~III breast cancer
• completed neoadjuvant or adjuvant taxane-based chemotherapy
• the average severity of CIPN is moderate to severe (NRS ?4)
• started standard treatment (Duloxetine) for CIPN within a month.
• ECOG ?3
• life expenctancy more than six months
• signed informed consent

Exclusion Criteria

• receiving chemotherapy.
• diagnosed with diabetic neuropathy.
• diagnosed with neuropathy from any type of nerve compression
• suspected alcohol or drug abuse
• having received acupuncture treatment in the past one month
• severe hemorrhagic coagulopathy or bleeding tendency.
• pregnant, lactating, or planning to be pregnant
• any other condition that the researcher considers to be inappropriate

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
BPI-SF average pain severity

Secondary Outcome Measures

Name	Time	Method
BPI-SF average pain severity;Functional Assessment of Cancer Therapy/Gynecologic Oncology Group – Neurotoxicity (FACT/GOC-NTX);Beck Depression Inventory-II (BDI-II);Brief Fatigue Inventory (BFI)